Salvage surgery for patients with recurrent gastrointestinal sarcoma. Prognostic factors to guide-patient selection

Cancer

Volumn 88, Issue 1, 2000, Pages 66-74

  Mudan, Satvinder S ^a,b   Conlon, Kevin C ^a   Woodruff, James M ^a   Lewis, Jonathan J ^a   Brennan, Murray F ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Gastrointestinal; Recurrent; Sarcoma; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; REOPERATION; SALVAGE THERAPY; SARCOMA; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; DISEASE-FREE SURVIVAL; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; REOPERATION; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SARCOMA; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0033976051     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000101)88:1<66::AID-CNCR10>3.0.CO;2-0     Document Type: Article

References (56)

1. Mack TM. Sarcomas and other malignancies of soft tissue, retroperitoneum, peritoneum, pleura, heart, mediastinum, and spleen. Cancer 1995;75(1 Suppl):211-44.
2. Lewis JJ, Brennan MF. Soft tissue sarcomas. Curr Prob Surg 1996;33(10):817-72.
3. Hurlimann J, Gardiol D. Gastrointestinal stromal tumours: an immunohistochemical study of 165 cases. Histopathology 1991;19(4):311-20.
4. Floyd CM, Ro JY, Ordonez NG, Mackay B. Stromal tumors of the gastrointestinal tract: Light microscopic, immunohistochemical, and ultrastructural observations on 50 cases. In: Watanabe S, Wolff M, Sommers SC, editors. Digestive disease pathology, vol 1. Philadelphia: Field & Wood, 1988; 165-177.
5. Hjermstad BM, Sobin LH, Helwig EB. Stromal tumors of the gastrointestinal tract: myogenic or neurogenic? [published erratum appears in Am J Surg Pathol 1987;11(8):660]. Am J Surg Pathol 1987;11(5):383-6.
6. Ma CK, Amin MB, Kintanar E, Linden MD, Zarbo RJ. Immunohistologic characterization of gastrointestinal stromal tumors: a study of 82 cases compared with 11 cases of leiomyomas. Mod Pathol 1993;6(2):139-44.
7. Miettinen M. Gastrointestinal stromal tumors. An immunohistochemical study of cellular differentiation. Am J Clin Pathol 1988;89(5):601-10.
8. Mikhael AI, Bacchi CE, Zarbo RJ, Ma CK, Gown AM. CD34 expression in stromal tumors of the gastrointestinal tract. Appl Immunohistochem 1994;2:89-93.
9. Pike AM, Lloyd RV, Appelman HD. Cell markers in gastrointestinal stromal tumors. Hum Pathol 1988;19(7):830-4.
10. Ueyama T, Guo KJ, Hashimoto H, Daimaru Y, Enjoji M. A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors. Cancer 1992;69(4):947-55.
11. Franquemont DW, Frierson HF Jr. Muscle differentiation and clinicopathologic features of gastrointestinal stromal tumors. Am J Surg Pathol 1992;16(10):947-54.
12. Miettinen M, Virolainen M, Maarit Sarlomo R. Gastrointestinal stromal tumors - value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. Am J Surg Pathol 1995;19(2):207-16.
13. Saul SH, Rast ML, Brooks JJ. The immunohistochemistry of gastrointestinal stromal tumors. Evidence supporting an origin from smooth muscle. Am J Surg Pathol 1987;11(6):464-73.
14. Suster S, Sorace D, Moran CA. Gastrointestinal stromal tumors with prominent myxoid matrix. Clinicopathologic, immunohistochemical, and ultrastructural study of nine cases of a distinctive morphologic variant of myogenic stromal tumor [see comments]. Am J Surg Pathol 1995; 19(1):59-70.
15. van de Rijn M, Hendrickson MR, Rouse RV. CD34 expression by gastrointestinal tract stromal tumors. Hum Pathol 1994; 25(8):766-71.
16. Lewin KJ, Riddell RH, Weinstein WM. Mesenchymal tumors gastrointestinal pathology and its clinical implications. New York: Igaku-Shoin, 1992:284-341.
17. Newman PL, Wadden C, Fletcher CD. Gastrointestinal stromal tumours: correlation of immunophenotype with clinicopathological features. J Pathol 1991;164(2):107-17.
18. Erlandson RA, Klimstra DS, Woodruff JM. Subclassification of gastrointestinal stromal tumors based on evaluation by electron microscopy and immunohistochemistry [see comments]. Ultrstruct Pathol 1996;20(4):373-93.
19. Herrera GA, Pinto de Moraes H, Grizzle WE, Han SG. Malignant small bowel neoplasm of enteric plexus derivation (plexosarcoma). Light and electron microscopic study confirming the origin of the neoplasm. Dig Dis Sci 1984;29(3): 275-84.
20. Walker P, Dvorak AM. Gastrointestinal autonomic nerve (GAN) tumor. Ultrastructural evidence for a newly recognized entity. Arch Pathol Lab Med 1986;110(4):309-16.
21. Herrera GA, Cerezo L, Jones JE, Sack J, Grizzle WE, Pollack WJ, et al. Gastrointestinal autonomic nerve tumors. "Plexo-sarcomas." Arch Pathol Lab Med 1989;113(8):846-53.
22. Lauwers GY, Erlandson RA, Casper ES, Brennan MF, Woodruff JM. Gastrointestinal autonomic nerve tumors: a clinicopathological, immunohistochemical and ultrastructural study of 12 cases. Am J Surg Pathol 1993;17: 887-97.
23. Sircar K, Hewlett B, Riddell H. Most gastrointestinal stromal tumors (GIST) arise from interstitial cells of Cajal (ICC). Mod Pathol 1998;11:71A.
24. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998;279(5350):577-80.
25. Rumessen JJ, Mikkelsen HB, Qvortrup K, Thuneberg L. Ultrastructure of interstitial cells of Cajal in circular muscle of human small intestine. Gastroenterology 1993;104(2):343-50.
26. Conlon KC, Casper ES, Brennan MF. Primary gastrointestinal sarcomas: analysis of prognostic variables. Ann Surg Oncol 1995;2(1):26-31.
27. Ng EH, Pollock RE, Romsdahl MM. Prognostic implications of patterns of failure for gastrointestinal leiomyosarcomas. Cancer 1992;69(6):1334-41.
28. Ng EH, Pollock RE, Munsell MF, Atkinson EN, Romsdahl MM. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging. Ann Surg 1992;215(1):68-77.
29. Skandalakis JE, Gray SW. Smooth muscle tumors of the alimentary tract. In: Ariel IM, editor. Progress in clinical cancer. New York: Grune & Stratton, 1965;692-708.
30. Golden T, Stout AP. Smooth muscle tumors of the gastrointestinal tract and retroperitoneal tissues. Surg Gynecol Obstet 1941;73:784-810.
31. McGrath PC, Neifeld JP, Lawrence W Jr., Kay S, Horsley JSd, Parker GA. Gastrointestinal sarcomas. Analysis of prognostic factors. Ann Surg 1987;206(6):706-10.
32. Lee YT. Leiomyosarcoma of the gastro-intestinal tract: general pattern of metastasis and recurrence. Cancer Treat Rev 1983;10(2):91-101.
33. Evans HL. Smooth muscle tumors of the gastrointestinal tract. A study of 56 cases followed for a minimum of 10 years. Cancer 1985;56(9):2242-50.
34. McGrath PC, Sloan DA, Kenady DE. Adjuvant therapy of soft-tissue sarcomas. Clin Plast Surg 1995;22(1):21-9.
35. Casper ES, Gaynor JJ, Harrison LB, Panicek D, Hadju SI, Brennan MF. Preoperative and postoperative adjuvant combination chemotherapy for adults with high grade soft tissue sarcoma. Cancer 1994;73:1644-51.
36. Verweij J, Pinedo HM. Adjuvant chemotherapy of soft tissue sarcomas. Cancer Treat Res 1997;91:173-87.
37. Alvegard T. Soft tissue sarcomas. Acta Oncol 1996;35(Suppl 7):117-22.
38. Mertens WC, Bramwell VH. Adjuvant chemotherapy for soft tissue sarcomas. Hematol Oncol Clin North Am 1995;9(4): 801-15.
39. Lewis JJ, Benedetti F. Adjuvant therapy for soft tissue sarcomas. Surg Oncol Clin North Am 1997;6(4):847-62.
40. Appelman H, Helwig EB. Cellular leiomyomas of the stomach in 49 patients. Arch Pathol Lab Med 1977;101(7):373-7.
41. Lindsay PC, Ordonez N, Raaf JH. Gastric leiomyosarcoma: clinical and pathological review of fifty patients. J Surg Oncol 1981;18(4):399-421.
42. Brennan MF, Casper ES, Harrison LB, Shiu MH, Gaynor J, Hajdu SI. The role of multimodality therapy in soft-tissue sarcoma [see comments and discussion]. Ann Surg 1991; 214(3):328-38.
43. Brennan MF, Hilaris B, Shiu MH, Lane J, Magill G, Friedrich C, et al. Local recurrence in adult soft-tissue sarcoma. A randomized trial of brachytherapy. Arch Surg 1987;122(11): 1289-93.
44. Rosenberg SA, Tepper J, Glatstein E, Costa J, Baker A, Brennan M, et al. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 1982;196(3):305-15.
45. Kinsella TJ, Sindelar WF, Lack E, Glatstein E, Rosenberg SA. Preliminary results of a randomized study of adjuvant radiation therapy in resectable adult retroperitoneal soft tissue sarcomas. J Clin Oncol 1988;6(1):18-25.
46. Jaques DP, Coit DG, Hajdu SI, Brennan MF. Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Ann Surg 1990;212(1):51-9.
47. Bevilacqua RG, Rogatko A, Hajdu SI, Brennan MF. Prognostic factors in primary retroperitoneal soft-tissue sarcomas. Arch Surg 1991;126(3):328-34.
48. Meijer S, Peretz T, Gaynor JJ, Tan C, Hajdu SI, Brennan MF. Primary colorectal sarcoma. A retrospective review and prognostic factor study of 50 consecutive patients. Arch Surg 1990;125(9):1163-8.
49. Dougherty MJ, Compton C, Talbert M, Wood WC. Sarcomas of the gastrointestinal tract. Separation into favorable and unfavorable prognostic groups by mitotic count. Ann Surg 1991;214(5):569-74.
50. Kimura H, Yonemura Y, Kadoya N, Kosaka T, Miwa K, Miyazaki I, et al. Prognostic factors in primary gastrointestinal leiomyosarcoma: a retrospective study [see discussion]. World J Surg 1991;15(6):771-67.
51. Singer S, Corson JM, Demetri GD, Healey EA, Marcus K, Eberlein TJ. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg 1995;221(2):185-95.
52. Karakousis CP, Gerstenbluth R, Kontzoglou K, Driscoll DL. Retroperitoneal sarcomas and their management. Arch Surg 1995;130(10):1104-9.
53. Heslin MJ, Lewis JJ, Nadler E, Newman E, Woodruff JM, Casper ES, et al. Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol 1997;15(8):2832-9.
54. Jaques DP, Coit DG, Casper ES, Brennan MF. Hepatic metastases from soft-tissue sarcoma. Ann Surg 1995;221(4):392-7.
55. Lewis JJ, Leung D, Heslin M, Woodruff JM, Brennan MF. Association of local recurrence with subsequent survival in extremity soft tissue sarcoma. J Clin Oncol 1997;15(2):646-52.
56. Evans RA. Soft tissue sarcoma: the enigma of local recurrence. J Surg Oncol 1993;53(2):88-91.